Clearside Biomedical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.About CLSD
Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases.
CEOGeorge M. Lasezkay
CEOGeorge M. Lasezkay
Employees32
Employees32
HeadquartersAlpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded2011
Founded2011
Employees32
Employees32
CLSD Key Statistics
Market cap31.77M
Market cap31.77M
Price-Earnings ratio-1.48
Price-Earnings ratio-1.48
Dividend yield—
Dividend yield—
Average volume509.68K
Average volume509.68K
High today$0.6399
High today$0.6399
Low today$0.3902
Low today$0.3902
Open price$0.58
Open price$0.58
Volume3.65M
Volume3.65M
52 Week high$1.65
52 Week high$1.65
52 Week low$0.3201
52 Week low$0.3201
CLSD News
TipRanks 13h
Clearside Biomedical downgraded to Neutral from Buy at H.C. WainwrightH.C. Wainwright downgraded Clearside Biomedical (CLSD) to Neutral from Buy without a price target after the company said it is exploring strategic alternatives....
TipRanks 1d
Clearside Biomedical downgraded to Hold from Buy at NeedhamNeedham downgraded Clearside Biomedical (CLSD) to Hold from Buy with a $3 price target Published first on TheFly – the ultimate source for real-time, market-mo...
Analyst ratings
86%
of 7 ratingsBuy
14.3%
Hold
85.7%
Sell
0%
People also own
Based on the portfolios of people who own CLSD. This list is generated using Robinhood data, and it’s not a recommendation.